COVID-19, the Immune System, and Organic Disability

IF 1.3 Q3 ETHICS Asian Bioethics Review Pub Date : 2022-11-14 DOI:10.1007/s41649-022-00232-3

Miguel Angel Ramiro Avilés, Íñigo De Miguel Beriain

引用次数: 0

Abstract

Despite the availability of safe vaccines against SARS-CoV-2, some people will remain vulnerable because they will not be vaccinated. Who are these non-vaccinated people? We can distinguish two groups: (i) persons who cannot be vaccinated for clinical reasons and who, despite having been vaccinated, have not achieved immunity; (ii) persons who voluntarily refuse to get vaccinated. These groups have in common an immune system that will make them vulnerable to COVID-19. The reasons for their vulnerability and the ethical judgment they deserve are different; the solutions offered to them are also different. In the case of those who voluntarily avoid vaccination, States are not compromised to introduce new protective policies. In the case of people who remain involuntarily vulnerable, instead, the response should be articulated on the same rules and principles that inform the social model of disability because they will live with an organic disability.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

新冠肺炎、免疫系统和器质性残疾

尽管有针对严重急性呼吸系统综合征冠状病毒2型的安全疫苗，但一些人仍然很脆弱，因为他们不会接种疫苗。这些未接种疫苗的人是谁？我们可以区分两组：（i）因临床原因无法接种疫苗的人和尽管接种了疫苗但尚未获得免疫力的人；（ii）自愿拒绝接种疫苗的人。这些群体有一个共同的免疫系统，这将使他们容易感染新冠肺炎。他们脆弱的原因和他们应该得到的道德评判是不同的；提供给他们的解决方案也有所不同。对于那些自愿避免接种疫苗的人，各州在引入新的保护政策方面不会妥协。相反，对于仍处于非自愿弱势的人，应对措施应基于与残疾社会模式相同的规则和原则，因为他们将生活在器质性残疾中。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Asian Bioethics Review Multiple-

CiteScore

6.20

自引率

3.40%

发文量

期刊介绍： Asian Bioethics Review (ABR) is an international academic journal, based in Asia, providing a forum to express and exchange original ideas on all aspects of bioethics, especially those relevant to the region. Published quarterly, the journal seeks to promote collaborative research among scholars in Asia or with an interest in Asia, as well as multi-cultural and multi-disciplinary bioethical studies more generally. It will appeal to all working on bioethical issues in biomedicine, healthcare, caregiving and patient support, genetics, law and governance, health systems and policy, science studies and research. ABR provides analyses, perspectives and insights into new approaches in bioethics, recent changes in biomedical law and policy, developments in capacity building and professional training, and voices or essays from a student’s perspective. The journal includes articles, research studies, target articles, case evaluations and commentaries. It also publishes book reviews and correspondence to the editor. ABR welcomes original papers from all countries, particularly those that relate to Asia. ABR is the flagship publication of the Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore. The Centre for Biomedical Ethics is a collaborating centre on bioethics of the World Health Organization.

期刊最新文献

Governance of Medical AI. Leonardo D. de Castro, 1952–2024 How the EU AI Act Seeks to Establish an Epistemic Environment of Trust. Existing and Emerging Capabilities in the Governance of Medical AI. Moving beyond Technical Issues to Stakeholder Involvement: Key Areas for Consideration in the Development of Human-Centred and Trusted AI in Healthcare.